Does OFATUMUMAB Cause Injection site extravasation? 65 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 65 reports of Injection site extravasation have been filed in association with OFATUMUMAB (ARZERRA). This represents 0.2% of all adverse event reports for OFATUMUMAB.
65
Reports of Injection site extravasation with OFATUMUMAB
0.2%
of all OFATUMUMAB reports
0
Deaths
2
Hospitalizations
How Dangerous Is Injection site extravasation From OFATUMUMAB?
Of the 65 reports, 2 (3.1%) required hospitalization.
Is Injection site extravasation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OFATUMUMAB. However, 65 reports have been filed with the FAERS database.
What Other Side Effects Does OFATUMUMAB Cause?
Fatigue (5,202)
Headache (4,430)
Pain (3,382)
Chills (3,372)
Pyrexia (3,370)
Influenza like illness (2,727)
Nausea (1,688)
Multiple sclerosis relapse (1,525)
Covid-19 (1,435)
Asthenia (1,393)
What Other Drugs Cause Injection site extravasation?
EXENATIDE (2,320)
ETANERCEPT (1,139)
ADALIMUMAB (381)
SEMAGLUTIDE (342)
VEDOLIZUMAB (237)
SOMATROPIN (230)
REGADENOSON (226)
RITUXIMAB (215)
EVOLOCUMAB (188)
DUPILUMAB (170)
Which OFATUMUMAB Alternatives Have Lower Injection site extravasation Risk?
OFATUMUMAB vs OFLOXACIN
OFATUMUMAB vs OLANZAPINE
OFATUMUMAB vs OLANZAPINE\SAMIDORPHAN L-MALATE
OFATUMUMAB vs OLAPARIB
OFATUMUMAB vs OLARATUMAB